In Vitro Fertilization (IVF) Market
Exactitude Consultancy Reports
The global in vitro fertilization (IVF) market is expected to reach USD 26.8 billion by 2025, from USD 16.5 billion in 2020, at a CAGR of 10.0%. The increase in this market is primarily due to the rising incidence of infertility, the growing preference for IVF treatments, and the availability of reimbursement policies.
According to a new report by Grand View Research, Inc., the global in vitro fertilization market is expected to reach USD 26.8 billion by 2025, growing at a CAGR of 10.0% over the forecast period. The increase in this market is driven by the rising incidence of infertility, the growing preference for IVF treatments, and the availability of reimbursement policies.
In vitro fertilization is a process of fertilization where an egg is combined with sperm outside the body, in vitro. The process involves monitoring and stimulating a woman’s ovulatory process, removing an ovum or ova (egg or eggs) from the woman’s ovaries and letting sperm fertilize them in a liquid in a laboratory.
The first test-tube baby was born in 1978. Since then, IVF has become a common fertility treatment. According to the Centers for Disease Control and Prevention (CDC), as of 2016, about 6% of all births in the United States, or about 1 in every 8 babies, were conceived using fertility treatments such as IVF.
There are a number of factors that are driving the growth of the IVF market. The rising incidence of infertility is one of the key factors driving the market growth. According to the National Infertility Association, about 10% of the reproductive-age population in the United States suffers from infertility. Additionally, the growing preference for IVF treatments is another key factor driving the market growth. IVF is considered to be the most effective fertility treatment available and is preferred over other fertility treatments, such as artificial insemination and intracytoplasmic sperm injection.